Key Takeaways
- Volume up 21%, but pricing drags revenue: Nine-month volume grew 21% while revenue dipped because raw material prices corrected and selling prices followed, compressing absolute margins even where percentage margins held.
- Pakhajan plant is the margin story: Trial runs have started, commercial production is targeted for end-March 2024, and the facility carries higher margins than the saturated Vapi plant, promising a ~200 bps consolidated margin lift over four to eight quarters.
- Export demand is subdued, not collapsing: The 62% export contribution and apparent export decline reflect lower freight components in selling prices and soft geography-level demand, not a structural loss of volume.
- US subsidiary opens a direct channel: A newly incorporated wholly owned subsidiary will serve as a US stock point to penetrate end users across the full 150-product portfolio, with the US already contributing over 40% of export revenue.
- What to watch next quarter: Whether the Q4 "spark" converts into sustained demand recovery, the Pakhajan plant receives commercial clearance by the March deadline, and how quickly certifications come through in the promised four-to-eight-week window.
Pakhajan Facility: Timeline, Ramp-Up & Margin Impact
- Commercial production imminent: Trial runs are underway and management is working with authorities to secure clearance for commercial production by end of March 2024.
- Certification process started: Applications for required certifications have been submitted; management hopes to receive them within the next four to eight weeks.
- Utilization ramp planned in phases: FY25 targets average 50% utilization across quarters, reaching 90% in the final quarter; FY26 is expected to run at full-year 90% utilization.
- Customer demand de-risked: Management has soft commitments and keen interest from customers for Pakhajan output and has already factored in the discount needed to place volumes in the market.
- Margin uplift is the core thesis: Pakhajan will carry higher margins than the current Vapi plant, whose peak efficiency sits at 18%; the consolidated operating margin improvement of ~200 bps over four to eight quarters will be driven mainly by Pakhajan, supplemented by a mix shift toward the higher-margin industrial segment.
- Funding secured, no dilution: Peak debt will reach about ₹500 crores by March; working capital debt for the ramp-up is tied up with bankers, and management confirmed no equity raise is needed.
- Vapi is fully saturated: There is no further debottlenecking possible at Vapi; the only capacity headroom comes from moving production to Pakhajan.
Parag Jhaveri: "We are factoring this selling price. We already factored in the discount what we need to offer in the market."
Margin Mechanics: What Drove the Decline
- Absolute margin compression from falling prices: When raw material prices were high, selling prices and absolute margins were larger; as purchase prices dropped, selling prices reduced, so absolute margin numbers fell even where percentage margins held steady.
- Consumer care segment a persistent drag: The consumer care segment is not contributing to margins and has been reducing, weighing on overall profitability.
- Forex adjustments sit in revenue, not other income: Forex policy adjustments driven by government rules are classified within sales or purchase differences, not below the line; management does not see a fall in absolute gross margins from this treatment.
- Cost-side tailwinds partially offset: Other expenses declined due to lower freight, reduced power and fuel costs, some repair savings, and the in-housing of job work previously done externally.
- Depreciation also eased: Depreciation fell because certain assets at Vapi reached full depreciation with limited additions during the year.
Parag Jhaveri: "If I'm selling a INR100 product, my margins are 40%, I make INR40."
Demand & Volume: The Pricing-Volume Disconnect
- Volume grew strongly, revenue did not: Nine-month volume grew 21%, but revenue dipped because pricing corrected alongside raw material costs; the Indian market grew 7-8% in volume terms, outpacing the company's 5% overall nine-month volume growth.
- Export demand subdued, not structurally broken: Export contribution stood at 62%, reflecting soft demand across geographies; the apparent export decline is largely a freight accounting effect, since freight is part of the sales line and has reduced, meaning real export volumes are not declining.
- Red Sea disruption a transit risk: The crisis may elongate shipment transit times, with potential knock-on effects for business.
- Raw material prices inching back up: Some raw material price correction has occurred, and prices are now rising slowly, though not at the speed they dropped.
- Pricing recovery still two quarters away: Management does not anticipate pricing growth in the next quarter; a rebound may come two quarters out, contingent on demand recovery in Asia and Europe.
Parag Jhaveri: "We don't anticipate happening in the next quarter. But it may happen down the line two quarters somewhere where the market will rebound overall, the demand rebound overall in an Asian country and also in the European world."
Q4 Outlook: A Spark, Not Yet a Fire
- Early Q4 signals are cautiously positive: Management sees a "spark" in Q4 but says it is too early to judge whether it converts into sustained demand or fades; the tone is watchful rather than declarative.
- No confirmation of trend change: When asked directly whether the challenges of the first nine months persist into Q4, management deflected, offering only the "spark" metaphor without confirming or denying improvement.
Parag Jhaveri: "We see there is some spark already. Now we have to wait and watch that this does this spark convert into fire or it just fizzle down. So, it's too early to comment on that going forward. But it looks promising."
US Subsidiary: Direct Distribution Play
- Newly incorporated, strategically timed: A wholly owned subsidiary in the United States has been set up to distribute products and serve as a local stock point, positioning the company to penetrate more deeply with end users.
- Full portfolio, not a single product: The subsidiary will cover the entire Yasho portfolio of 150 products, not just any one industrial product.
- US is already the largest export market: The US contributes more than 40% of export revenue, making direct presence a logical next step to capture incremental demand.
Parag Jhaveri: "US is contributing more than 40% revenue in exports. If you look at the 100% pie chart, USA comes in with more than 40%. And here we want to penetrate more with the end user."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Pakhajan commercial production | Receive clearance from authorities | End of March 2024 |
| Pakhajan certifications | Receive required certifications | Within next four to eight weeks |
| Pakhajan utilization | Average 50% across FY25, 90% in last quarter; FY26 full year at 90% | FY25 ramp, FY26 full |
| Peak debt | ~₹500 crores, no equity raise needed | By March 2024 |
| Consolidated operating margin improvement | ~200 bps lift, driven by Pakhajan and industrial segment mix shift | Over next four to eight quarters |
| Pricing recovery | No growth next quarter; possible rebound when Asian and European demand recovers | Two quarters out (conditional) |
Key Metrics
| Metric | Q3 FY24 |
|---|---|
| Revenue from industrial segment | 87% of total revenue for the quarter, 84% for nine months |
| Export contribution | 62% of revenue |
| Volume growth | 21% YoY |
| Nine-month volume growth | 5% overall |
| Indian market volume growth | 7% to 8% |
| Capacity utilization | 88% to 90% in FY24, currently at 85% |
| Vapi plant peak revenue potential | ₹650-₹700 cr, revised down from ₹700-₹750 cr at current prices |
| Pakhajan plant peak revenue potential | ₹550 cr, revised down from ₹550-₹600 cr at current prices |
| Pakhajan expected utilization FY25 | 50% average, ramping to 90% in last quarter of FY25 |
| Pakhajan expected utilization FY26 | 90% full year |
| Peak debt | ₹500 cr by March |
| Debt breakup | ₹270 cr Pakhajan, ₹30 cr Vapi, ₹200 cr working capital |
| US share of export revenue | More than 40% |
| Peak EBITDA of Vapi facility | ₹120-₹130 cr (per an analyst's math) |
| Operating margin outlook | Improvement of ~2 percentage points over next 4-8 quarters |